ALB SOLUTIONS
​Strategic advisory firm.
- Active Clients
- 15
- TTM Spend
- $1,780,000
- Total Filings
- 207
- Active Since
- 2021
trailing 4 reported quarters
income + expenses, last 12mo
44 in the last 12 months
6 years with filings
Income & Lobbyist Activity Last 10 years, by quarter
Clients from the last four reported quarters (15) · ranked by reported income and expenses
| Client | Reported $ | Filings | Share |
|---|---|---|---|
| CVS HEALTH (AND SUBSIDIARIES) | $190.0K | 3 | 10.7% |
| ELEVANCE HEALTH, INC. | $180.0K | 3 | 10.1% |
| BLUE CROSS AND BLUE SHIELD ASSOCIATION | $170.0K | 3 | 9.6% |
| HUMANA, INC. | $160.0K | 3 | 9.0% |
| AMERICAN HEART ASSOCIATION | $150.0K | 3 | 8.4% |
| BETTER SOLUTIONS FOR HEALTHCARE | $150.0K | 3 | 8.4% |
| BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | $120.0K | 3 | 6.7% |
| CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATES | $100.0K | 3 | 5.6% |
| VERTEX PHARMACEUTICALS | $100.0K | 3 | 5.6% |
| CENTENE CORPORATIONS | $90.0K | 3 | 5.1% |
| THE LEUKEMIA & LYMPHOMA SOCIETY | $90.0K | 2 | 5.1% |
| AIS HEALTHCARE | $80.0K | 3 | 4.5% |
| INDEPENDENCE BLUE CROSS | $80.0K | 3 | 4.5% |
| CAREVISO INC. | $60.0K | 3 | 3.4% |
| SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATION | $60.0K | 3 | 3.4% |
Issues lobbied last four reported quarters
| Issue | Activities | Share |
|---|---|---|
HCR
Health Issues
|
32 | 64.0% |
PHA
Pharmacy
|
6 | 12.0% |
MAN
Manufacturing
|
3 | 6.0% |
MMM
Medicare/Medicaid
|
3 | 6.0% |
TAR
Tariff (miscellaneous tariff bills)
|
3 | 6.0% |
TRD
Trade (domestic/foreign)
|
3 | 6.0% |
Government entities contacted last four reported quarters
| Entity | Contacts | Share | Type |
|---|---|---|---|
| HOUSE OF REPRESENTATIVES | 43 | 35.2% | Congress |
| SENATE | 43 | 35.2% | Congress |
| Health & Human Services, Dept of (HHS) | 21 | 17.2% | Agency |
| White House Office | 9 | 7.4% | Agency |
| Food & Drug Administration (FDA) | 6 | 4.9% | Agency |
Revolving door lobbyists active in the last 12 months
2 of 2 lobbyists (100%) listed a prior covered government position on a lobbying filing.
- ADAM BUCKALEW
- Covered Official Positions Continued: Deputy Chief of Staff, U.S. Rep. Markwayne Mullin (R-OK); Communications Director & Legislative Assistant, U.S. Rep. Gre...
- VERONICA JACKSON
- Director, Strategic Planning, Office of the Assistant Secretary for Public Affairs, HHS
Political contributions semiannual LD-203 reports by the firm and its lobbyists
1 report on file for 2025 (latest version of each); 1 reported no contributions.
No itemized contributions on these reports.
Filings 207 total
| Posted | Period | Client | Type | Income | Expenses | Activities | Lobbyists |
|---|---|---|---|---|---|---|---|
| 2026-07-16 | 2026 Q2 | VERTEX PHARMACEUTICALS | 2nd Quarter - Report |
$50.0K | — | 1 | 2 |
| 2026-07-16 | 2026 Q2 | SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATION | 2nd Quarter - Report |
$30.0K | — | 3 | 2 |
| 2026-07-16 | 2026 Q2 | INDEPENDENCE BLUE CROSS | 2nd Quarter - Report |
$40.0K | — | 1 | 2 |
| 2026-07-16 | 2026 Q2 | HUMANA, INC. | 2nd Quarter - Report |
$60.0K | — | 1 | 2 |
| 2026-07-16 | 2026 Q2 | ELEVANCE HEALTH, INC. | 2nd Quarter - Report |
$60.0K | — | 1 | 2 |
| 2026-07-16 | 2026 Q2 | CVS HEALTH (AND SUBSIDIARIES) | 2nd Quarter - Report |
$70.0K | — | 1 | 2 |
| 2026-07-16 | 2026 Q2 | CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATES | 2nd Quarter - Report |
$50.0K | — | 1 | 2 |
| 2026-07-16 | 2026 Q2 | CENTENE CORPORATIONS | 2nd Quarter - Report |
$30.0K | — | 1 | 2 |
| 2026-07-16 | 2026 Q2 | CAREVISO INC. | 2nd Quarter - Report |
$20.0K | — | 1 | 1 |
| 2026-07-16 | 2026 Q2 | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2nd Quarter - Report |
$40.0K | — | 1 | 2 |
Lobbyists active in the last 12 months (2)
- ADAM BUCKALEW · prior govt
- VERONICA JACKSON · prior govt